Comprehensive analysis of vaginal microbiota in Chinese women with genital tuberculosis: implications for diagnosis and treatment.

Comprehensive analysis of vaginal microbiota in Chinese women with genital tuberculosis: implications for diagnosis and treatment.

Publication date: Jan 28, 2025

Tuberculosis remains an infectious disease of global concern, with potential impacts on respiratory and intestinal microbiota owing to prolonged broad-spectrum antibiotic therapy. Despite its potential to cause infertility, the vaginal microbiota of women with genital tuberculosis remains poorly understood. We comprehensively analyzed the vaginal microbiota in Chinese women with genital tuberculosis. We recruited women with pelvic (n = 28), endometrial (n = 16), and pulmonary (n = 12) tuberculosis as the research group, and healthy women (n = 11) as the control group. Vaginal discharges were collected for metagenomic analysis of its microbiota. The alpha diversity of the vaginal microbiota in women with genital tuberculosis was slightly higher than that in healthy women, though the difference was not statistically significant (P = 0. 23). Similarly, no significant differences in alpha diversity were observed between women with genital and pulmonary tuberculosis (P = 0. 82) or between those with pelvic and endometrial tuberculosis (P = 0. 82). Notably, the lowest alpha diversity was recorded six months to one year after initiating anti-tuberculosis treatment, with this decline being statistically significant (P = 0. 023). The dominance of Lactobacillus iners in the vaginal microbiota was more common in women with genital tuberculosis than that of Lactobacillus crispatus. Furthermore, the abundance of short-chain fatty acid -producing anaerobes, such as Actinomycetes, Streptococcus, and Finegoldia, were significantly increased. Short-chain fatty acid precursor pathways, including the ko03010 ribosome pathway, ko00970 aminoacyl-tRNA synthesis, ko00230 purine metabolism, ko00240 pyrimidine metabolism, and ko00010 glycolysis gluconeogenesis pathway, were significantly upregulated in women with endometrial tuberculosis. Extrapulmonary tuberculosis, particularly genital tuberculosis and its associated vaginal dysbiosis impacts female fecundity. Vaginal dysbiosis is more pronounced when M. tuberculosis invades the endometrium. Given the effect of antibiotics on vaginal flora, probiotic combined interventions could be used as a future research direction. Not applicable.

Open Access PDF

Concepts Keywords
Chinese Adult
Ko00240 Antibiotic therapy
Probiotic Antitubercular Agents
Tuberculosis Antitubercular Agents
Women Bacteria
China
East Asian People
Female
Female infertility
Genital tuberculosis
Humans
Lactobacillus
Metagenomics
Microbiota
Middle Aged
Short-chain fatty acids
Tuberculosis, Female Genital
Vagina
Vaginal microbiota
Young Adult

Semantics

Type Source Name
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH infectious disease
pathway REACTOME Infectious disease
disease MESH infertility
disease MESH Vaginal discharges
disease MESH pulmonary tuberculosis
pathway KEGG Ribosome
pathway KEGG Purine metabolism
pathway KEGG Pyrimidine metabolism
pathway REACTOME Glycolysis
pathway REACTOME Gluconeogenesis
disease MESH Extrapulmonary tuberculosis
disease MESH dysbiosis
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
pathway REACTOME Fatty acids
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH death
disease MESH latent tuberculosis
disease MESH morbidity
disease IDO host
drug DRUGBANK Tretamine
disease IDO commensal
disease IDO susceptibility
disease MESH infection
disease MESH inflammation
disease MESH complications
disease IDO blood
disease MESH sexually transmitted infections
disease MESH pregnancy outcomes
disease IDO bacteria
drug DRUGBANK Trestolone
drug DRUGBANK Dimercaprol
disease IDO opportunistic pathogen
drug DRUGBANK Amino acids
drug DRUGBANK Acetic acid
drug DRUGBANK Acetate ion
drug DRUGBANK Butyric Acid
drug DRUGBANK Lactic Acid
disease IDO production
pathway KEGG Metabolic pathways
pathway REACTOME Metabolism
disease IDO history
disease MESH tumor
disease MESH peritoneal fluid
disease MESH ascites
drug DRUGBANK Methylergometrine
disease MESH vaginitis
disease MESH Vulvovaginal candidiasis
disease IDO quality
disease MESH respiratory diseases
drug DRUGBANK Guanosine
disease MESH Vaginal diseases
disease MESH abscess
disease MESH endometriosis
disease MESH Female infertility
disease MESH Tuberculosis Female Genital

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *